Homocysteine induces iron-catalyzed lipid peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol. 1994

K Hirano, and T Ogihara, and M Miki, and H Yasuda, and H Tamai, and N Kawamura, and M Mino
Department of Pediatrics, Osaka Medical College, Japan.

Homocystinuria is an inborn error of methionine metabolism that is characterized by the premature development of arteriosclerosis. As one of the major factors in the pathogenesis of arteriosclerosis, modification of low-density lipoprotein (LDL) has received widespread attention by many investigators. In this study, to elucidate the relationship between elevated homocysteine levels and premature arteriosclerosis, we investigated the role of homocysteine in the iron-catalyzed oxidative modification of LDL. When LDL isolated from a healthy subject was incubated with homocysteine and ferric ion, a gradual decrease of polyunsaturated fatty acids (PUFA), formation of thiobarbituric acid-reactive substances (TBARS) and fluorescent substances, and the fragmentation of apoprotein B (apoB) were observed. The extent of oxidative modification was dependent on the concentration of homocysteine. Modification of LDL was suppressed until the remaining alpha-tocopherol concentration reached a critical level. When the alpha-tocopherol content of LDL was increased by 2.6-fold, both the formation of TBARS and the fragmentation of apoB were suppressed. These results suggest that homocysteine might promote iron-catalyzed oxidation of LDL and imply its role for the development of premature arteriosclerosis.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008297 Male Males
D006710 Homocysteine A thiol-containing amino acid formed by a demethylation of METHIONINE. 2-amino-4-mercaptobutyric acid,Homocysteine, L-Isomer,2 amino 4 mercaptobutyric acid,Homocysteine, L Isomer,L-Isomer Homocysteine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D014810 Vitamin E A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid

Related Publications

K Hirano, and T Ogihara, and M Miki, and H Yasuda, and H Tamai, and N Kawamura, and M Mino
March 1991, Proceedings of the National Academy of Sciences of the United States of America,
K Hirano, and T Ogihara, and M Miki, and H Yasuda, and H Tamai, and N Kawamura, and M Mino
January 1988, Basic life sciences,
K Hirano, and T Ogihara, and M Miki, and H Yasuda, and H Tamai, and N Kawamura, and M Mino
June 2002, Chemical research in toxicology,
K Hirano, and T Ogihara, and M Miki, and H Yasuda, and H Tamai, and N Kawamura, and M Mino
December 1996, The Journal of biological chemistry,
K Hirano, and T Ogihara, and M Miki, and H Yasuda, and H Tamai, and N Kawamura, and M Mino
January 1990, The Biochemical journal,
K Hirano, and T Ogihara, and M Miki, and H Yasuda, and H Tamai, and N Kawamura, and M Mino
October 2000, Journal of lipid research,
K Hirano, and T Ogihara, and M Miki, and H Yasuda, and H Tamai, and N Kawamura, and M Mino
August 1991, Xenobiotica; the fate of foreign compounds in biological systems,
K Hirano, and T Ogihara, and M Miki, and H Yasuda, and H Tamai, and N Kawamura, and M Mino
June 1994, The Journal of biological chemistry,
K Hirano, and T Ogihara, and M Miki, and H Yasuda, and H Tamai, and N Kawamura, and M Mino
August 1983, Journal of lipid research,
K Hirano, and T Ogihara, and M Miki, and H Yasuda, and H Tamai, and N Kawamura, and M Mino
June 1984, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!